Arnaud Latil

715 total citations
17 papers, 592 citations indexed

About

Arnaud Latil is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Arnaud Latil has authored 17 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Arnaud Latil's work include Prostate Cancer Treatment and Research (7 papers), Genetic factors in colorectal cancer (2 papers) and Phytochemistry and Bioactive Compounds (1 paper). Arnaud Latil is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Genetic factors in colorectal cancer (2 papers) and Phytochemistry and Bioactive Compounds (1 paper). Arnaud Latil collaborates with scholars based in France, Belgium and Germany. Arnaud Latil's co-authors include Rosette Lidereau, Olivier Cussenot, Ivan Bièche, Georges Fournier, Patricia Berthon, Michel Vidaud, Dominique Vidaud, Antoine Valéri, Sandrine Pesche and Jean‐Claude Baron and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Journal of Investigative Dermatology.

In The Last Decade

Arnaud Latil

16 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnaud Latil France 9 305 252 172 161 126 17 592
Gregg Magrane United States 10 325 1.1× 69 0.3× 165 1.0× 87 0.5× 182 1.4× 15 578
Maria Teresa Radice Italy 8 373 1.2× 44 0.2× 128 0.7× 70 0.4× 118 0.9× 11 575
Chi-Ming Li United States 8 500 1.6× 78 0.3× 115 0.7× 76 0.5× 68 0.5× 8 667
Isuzu Ikeda Japan 9 292 1.0× 48 0.2× 85 0.5× 66 0.4× 137 1.1× 12 487
Cláudia Miranda Italy 11 223 0.7× 72 0.3× 35 0.2× 52 0.3× 143 1.1× 15 411
Gavin White United Kingdom 16 477 1.6× 61 0.2× 183 1.1× 90 0.6× 191 1.5× 23 786
Jonathan Perk United States 7 782 2.6× 88 0.3× 245 1.4× 193 1.2× 272 2.2× 7 994
Annette Düwel Spain 10 397 1.3× 52 0.2× 92 0.5× 50 0.3× 68 0.5× 13 575
Daniella Bianchi‐Frias United States 11 284 0.9× 200 0.8× 36 0.2× 107 0.7× 142 1.1× 13 545

Countries citing papers authored by Arnaud Latil

Since Specialization
Citations

This map shows the geographic impact of Arnaud Latil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Latil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Latil more than expected).

Fields of papers citing papers by Arnaud Latil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Latil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Latil. The network helps show where Arnaud Latil may publish in the future.

Co-authorship network of co-authors of Arnaud Latil

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Latil. A scholar is included among the top collaborators of Arnaud Latil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Latil. Arnaud Latil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Latil, Arnaud. (2020). En attendant la Déclaration de droits fondamentaux du numérique. HAL (Le Centre pour la Communication Scientifique Directe). 593. 1 indexed citations
2.
Libon, Christine, et al.. (2018). 1074 Mimosa pudica plant cell culture extracts (mimosine free) exhibit anti-inflammatory activities and inhibit the responses in vitro. Journal of Investigative Dermatology. 138(5). S182–S182.
3.
Latil, Arnaud. (2017). Le plagiat au défi du droit. N° 1(1). 61–79. 1 indexed citations
4.
Pfuhler, Stefan, Rolf Fautz, Gladys Ouédraogo, et al.. (2013). The Cosmetics Europe strategy for animal-free genotoxicity testing: Project status up-date. Toxicology in Vitro. 28(1). 18–23. 44 indexed citations
5.
Latil, Arnaud, et al.. (2010). 630 ANTI-INFLAMMATORY PROPERTIES OF PERMIXON LIPIDOSTEROLIC EXTRACT OF SERENOA REPENS: IN VITRO AND IN VIVO RESULTS. European Urology Supplements. 9(2). 209–209. 3 indexed citations
6.
Latil, Arnaud, et al.. (2009). 352 PERMIXON LIPIDOSTEROLIC EXTRACT OF SERENOA REPENS MODIFIES PROSTATE INFLAMMATORY STATUS. European Urology Supplements. 8(4). 208–208. 3 indexed citations
7.
Thuret, Rodolphe, Karine Chantrel-Groussard, Pierre Teillac, et al.. (2005). Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer. British Journal of Cancer. 92(2). 236–240. 20 indexed citations
8.
Valéri, Antoine, L. Cormier, B Cochand‐Priollet, et al.. (2003). Involvement of polymorphisms in androgen/oestrogen regulating genes on latent and clinical prostate cancers. European Urology Supplements. 2(1). 84–84. 2 indexed citations
9.
Cochand‐Priollet, B, Philippe Mangin, George Fournier, et al.. (2002). Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate. European Journal of Endocrinology. 147(4). 479–484. 21 indexed citations
10.
Latil, Arnaud, Ivan Bièche, Dominique Vidaud, et al.. (2001). Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.. PubMed. 61(5). 1919–26. 207 indexed citations
11.
Latil, Arnaud, Ivan Bièche, Sandrine Pesche, et al.. (2000). VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. International Journal of Cancer. 89(2). 167–171. 164 indexed citations
12.
Bièche, Ivan, et al.. (1997). Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma. British Journal of Cancer. 76(11). 1416–1418. 15 indexed citations
13.
Fournier, Georges, Arnaud Latil, Yolande Amet, et al.. (1995). Gene amplifications in advanced-stage human prostate cancer. Urological Research. 22(6). 343–347. 29 indexed citations
14.
Latil, Arnaud, Olivier Cussenot, Georges Fournier, Jean‐Claude Baron, & Rosette Lidereau. (1995). 453 Loss of heterozygosity at 7Q31 is a frequent and early event in prostate cancer. European Journal of Cancer. 31. S97–S97. 25 indexed citations
15.
Latil, Arnaud, Olivier Cussenot, Georges Fournier, Jean‐Claude Baron, & Rosette Lidereau. (1995). Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.. PubMed. 1(11). 1385–9. 54 indexed citations
16.
Latil, Arnaud, Olivier Cussenot, Georges Fournier, et al.. (1995). [Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q].. PubMed. 82(7). 589–97. 2 indexed citations
17.
Bièche, Ivan, et al.. (1992). [Association studies in cancerology: the example of gene L-myc polymorphism associated with the incidence of pulmonary metastases in breast cancers].. PubMed. 79(12). 1149–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026